Jennifer A. Woymach, MD | Authors

Articles

Exploring Novel Ibrutinib Combinations in Clinical Trials for CLL

January 16, 2020

Jennifer A. Woymach, MD, provides background information on the AO41702 study, which evaluates targeted therapy ibrutinib or ibrutinib plus rituximab in elderly patients with previously untreated chronic lymphocytic leukemia.